Friday, March 30, 2012

Daily News Digest: Reuters Health News Headlines - Yahoo! News

Daily News Alert
Yahoo! Alerts Yahoo! News | My Alerts | Edit Alert
Friday, March 30, 2012 12:05 AM PDT
Today's Reuters Health News Headlines - Yahoo! News:
Dow back in black as Wall St cuts losses near
Thu,29 Mar 2012 11:27 PM PDT
Reuters - NEW YORK (Reuters) - The Dow managed a slim gain on Thursday while the S&P 500 and the Nasdaq shook off most of their earlier losses to end slightly lower, as investors took advantage of a selloff to buy blue chips that have been rallying throughout the quarter. The Dow industrials sharply erased losses in the last half hour of trading and closed up 0.2 percent. Despite the S&P 500 marking its third day of declines, the benchmark index is still up 2.8 percent for the month and nearly 12 percent for the year. ... Full Story
Top

Mid-life Britain opens doors for disease research
Thu,29 Mar 2012 11:27 PM PDT
Reuters -

To match Special Report SCIENCE/GENOMELONDON (Reuters) - The world's biggest and most detailed biomedical database opened its doors to researchers on Friday, offering scientists a unique glimpse into the health and lifestyles of 500,000 middle-aged Britons. The UK Biobank - with more than 1,000 pieces of information about each participant plus samples of blood, urine and saliva - will be available to researchers worldwide, on the condition they put their findings back into the public domain. ...


Full Story
Top

Roche says development drug helps in breast cancer
Thu,29 Mar 2012 10:21 PM PDT
Reuters - ZURICH (Reuters) - Roche said patients with an aggressive type of breast cancer lived longer after taking an experimental "armed antibody" drug without the disease worsening than patients taking a combination of GlaxoSmithKline drug Tykerb and Roche's Xeloda. Though Roche said the Phase III data are not yet mature, the safety of the development drug -- dubbed T-DM1 -- is consistent with previous studies. Roche said it plans to submit the treatment to European and U.S. authorities for approval this year. (Reporting By Katharina Bart) Full Story
Top

Insight: New doubts about prostate-cancer vaccine Provenge
Thu,29 Mar 2012 10:08 PM PDT
Reuters - NEW YORK (Reuters) - Prostate cancer vaccine Provenge has long incited passions unlike any other cancer therapy. Doctors who raised doubts about it received death threats. Health regulators and lawmakers faced loud protests at their offices. A physician at the American Cancer Society was so intimidated by Provenge partisans that he yanked a skeptical discussion of it from his blog. The vitriol dissipated in April 2010, when the U.S. ... Full Story
Top

"Pink slime" producer allows tour of plant to bolster image
Thu,29 Mar 2012 09:27 PM PDT
Reuters - SOUTH SIOUX CITY, Neb (Reuters) - A maker of the hamburger filler branded by critics as "pink slime" on Thursday allowed three state governors supportive of the beef industry and a handful of journalists to see it being made for the first time since a controversy erupted over use of the meat scraps. Beef Products Inc, the leading producer of the filler the industry calls "finely textured beef," opened its meat plant in South Sioux City, Nebraska in a remote area straddling Nebraska, Iowa and South Dakota. ... Full Story
Top

JetBlue co-pilot calmly and quickly got jet down
Thu,29 Mar 2012 08:01 PM PDT
Reuters -

File photo of pilot Clayton Osbon being removed from a JetBlue passenger jet in AmarilloWASHINGTON/CHICAGO (Reuters) - With his captain restrained and locked out of the cockpit, the co-pilot of JetBlue Flight 191 acted calmly and quickly to get the Airbus jet and 135 other passengers and crew down safely. First Officer Jason Dowd was able to quietly signal to flight attendants on Tuesday that Captain Clayton Osbon, who abruptly left the cockpit and witnesses said in court documents had been screaming incoherently about religion and terrorists, might need to be restrained in the cabin. ...


Full Story
Top

Chavez back in Venezuela after radiation therapy
Thu,29 Mar 2012 07:44 PM PDT
Reuters -

Venezuelan President Hugo Chavez (C) smiles as he gestures inside Miraflores Palace in CaracasCARACAS (Reuters) - President Hugo Chavez returned home to Venezuela on Thursday after a first session of radiation treatment in Cuba that he hopes will cure his cancer and allow him to win a new six-year term in October. The 57-year-old socialist leader has said he will be flying back and forth to Havana over the coming weeks as he undergoes therapy, removing himself from the political stage just as his election rival ramps up his campaign. ...


Full Story
Top

Mid-life Britain opens doors for disease research
Thu,29 Mar 2012 05:00 PM PDT
Reuters -

To match Special Report SCIENCE/GENOMELONDON (Reuters) - The world's biggest and most detailed biomedical database opened its doors to researchers on Friday, offering scientists a unique glimpse into the health and lifestyles of 500,000 middle-aged Britons. The UK Biobank - with more than 1,000 pieces of information about each participant plus samples of blood, urine and saliva - will be available to researchers worldwide, on the condition they put their findings back into the public domain. ...


Full Story
Top

Analysis: Obama could see silver lining if healthcare law rejected
Thu,29 Mar 2012 04:57 PM PDT
Reuters -

U.S. President Obama speaks in the East Room at the White House in WashingtonWASHINGTON (Reuters) - The conventional wisdom is that it would be a political disaster for Democratic President Barack Obama, and a boon for Republicans, if the U.S. Supreme Court strikes down all or most of Obama's healthcare overhaul. That could be: The healthcare law - which among other things would require most Americans to buy health insurance - is Obama's signature achievement in domestic policy, and the number-one target of many Republicans in this year's elections. ...


Full Story
Top

House vote sets up Republican budget as manifesto, target
Thu,29 Mar 2012 04:47 PM PDT
Reuters -

House Budget Chairman Ryan shows a copy of the WASHINGTON (Reuters) - House Republicans passed congressman Paul Ryan's deficit-cutting budget plan on Thursday, setting it up as a central theme for their election-year campaign efforts and as a target for Democratic attacks over its proposed healthcare cuts. In a preview of the messages they will carry home to their constituents during a two-week break, Republicans hailed the plan as a bold step toward reining in U.S. deficits, while Democrats decried it as an assault on the cherished Medicare healthcare system for the elderly. ...


Full Story
Top

Obesity drugs need heart studies, U.S. advisers say
Thu,29 Mar 2012 04:26 PM PDT
Reuters - SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration voted 17-6 that regulators should make companies conduct heart impact studies in order to sell their drugs in the United States, even if clinical trials do not initially show evidence of increased heart risk. "Anti-obesity drugs have a bad track record of cardiovascular risk," said Dr. ... Full Story
Top

Analysis: Chief Justice Roberts may cast deciding healthcare vote
Thu,29 Mar 2012 02:21 PM PDT
Reuters -

U.S. Supreme Court Chief Justice John Roberts poses for an official photograph with the other Justices at the Supreme Court in WashingtonWASHINGTON (Reuters) - During three days of historic healthcare arguments at the Supreme Court, Chief Justice John Roberts presided with a steady calm and folksy charm. From his center seat on the nine-member bench, Roberts gently mediated as colleagues interrupted one another's questions this week. He offered a break in arguments on Tuesday so spectators in the packed courtroom could briefly stand and stretch, and then at the end of that Day Two, warmly told lawyers, "Counsel, we'll see you tomorrow. ...


Full Story
Top

Ibuprofen may help ward off altitude sickness
Thu,29 Mar 2012 01:48 PM PDT
Reuters - NEW YORK (Reuters Health) - A new study suggests that taking ibuprofen before a trip to the mountains may help some people avoid the headaches and nausea that come with altitude sickness. Still, both a study author and one altitude expert not involved in the research said the approach won't help all travelers and climbers -- and isn't necessarily any better than taking prescription altitude-sickness drugs. Even with ibuprofen, "there are still a lot of people who do have symptoms," said Robert Roach, head of the Altitude Research Center at the University of Colorado Denver School of Medicine. ... Full Story
Top

Electronic health records mean fewer tests: study
Thu,29 Mar 2012 01:41 PM PDT
Reuters - NEW YORK (Reuters Health) - Doctors order fewer lab tests when they have access to a patient's electronic medical records, according to a new study, but the efficiency may be confined to state-of-the-art records exchanges for now. The new study is based on the experience of two hospitals -- Brigham and Women's and Massachusetts General -- that form Partners HealthCare, a not-for-profit healthcare system in Boston. The findings are at odds with another recent study. In the year 2000, the two hospitals established a health information exchange to access each others' electronic medical records. ... Full Story
Top

Too little calcium, water linked to kidney stones
Thu,29 Mar 2012 01:06 PM PDT
Reuters - NEW YORK (Reuters Health) - Older women whose diet include too little calcium or water -- or too much salt -- have an increased risk of developing kidney stones, a study confirms. Researchers found that among more than 78,000 U.S. women in their 50s and 70s, the risk of developing first-time kidney stones declined as calcium or fluid intake climbed. On the other hand, the odds went up with a higher sodium intake. Kidney stones develop when the urine contains more crystal-forming substances -- like calcium, uric acid and a compound called oxalate -- than can be diluted by the available fluid. ... Full Story
Top



You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment